Scarica l'app Stockscreener
20.10
2.24%
0.44
Dopo l'orario di chiusura:
20.20
0.10
+0.50%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BAX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$19.66
Aprire:
$19.5
Volume 24 ore:
5.07M
Relative Volume:
0.67
Capitalizzazione di mercato:
$10.38B
Reddito:
$11.32B
Utile/perdita netta:
$-981.00M
Rapporto P/E:
-10.29
EPS:
-1.9532
Flusso di cassa netto:
$714.00M
1 W Prestazione:
-1.76%
1M Prestazione:
+4.80%
6M Prestazione:
+6.18%
1 anno Prestazione:
-32.98%
Intervallo 1D:
$19.42
$20.17
Intervallo di 1 settimana:
$19.38
$20.62
Portata 52W:
$15.73
$31.75
Baxter International Inc Stock (BAX) Company Profile
Nome
Baxter International Inc
Settore
Industria
Telefono
(224) 948-2000
Indirizzo
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
20.10 | 10.27B | 11.32B | -981.00M | 714.00M | -1.9532 |
ISRG
Intuitive Surgical Inc
|
403.18 | 144.07B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
143.92 | 39.67B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
66.12 | 31.54B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
35.30 | 30.39B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
191.26 | 27.36B | 5.54B | 1.52B | 1.74B | 10.37 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-31 | Downgrade | Argus | Buy → Hold |
| 2025-08-04 | Downgrade | Stifel | Buy → Hold |
| 2025-08-01 | Downgrade | Goldman | Buy → Neutral |
| 2025-02-26 | Ripresa | Goldman | Buy |
| 2025-02-24 | Aggiornamento | Argus | Hold → Buy |
| 2025-02-20 | Ripresa | Barclays | Overweight |
| 2024-07-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-10 | Downgrade | TD Cowen | Buy → Hold |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-01-06 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-12-19 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-12-15 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-12-12 | Downgrade | Citigroup | Buy → Neutral |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-06-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Downgrade | Goldman | Neutral → Sell |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-18 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | Reiterato | Morgan Stanley | Overweight |
| 2022-02-18 | Reiterato | Raymond James | Outperform |
| 2022-02-18 | Reiterato | Stifel | Buy |
| 2022-02-18 | Reiterato | UBS | Neutral |
| 2022-02-18 | Reiterato | Wells Fargo | Overweight |
| 2022-02-11 | Iniziato | Goldman | Neutral |
| 2022-01-07 | Ripresa | Citigroup | Buy |
| 2022-01-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2021-09-03 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2021-01-29 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | Downgrade | UBS | Buy → Neutral |
| 2020-12-15 | Downgrade | Goldman | Buy → Neutral |
| 2020-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-09-04 | Downgrade | Argus | Buy → Hold |
| 2020-06-24 | Iniziato | Oppenheimer | Outperform |
| 2020-03-19 | Aggiornamento | Stifel | Hold → Buy |
| 2020-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-02 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-12-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-01-02 | Aggiornamento | Citigroup | Neutral → Buy |
| 2019-01-02 | Aggiornamento | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | Aggiornamento | Argus | Hold → Buy |
| 2018-10-16 | Iniziato | Barclays | Underweight |
| 2018-05-17 | Ripresa | Piper Jaffray | Overweight |
| 2018-02-06 | Reiterato | Citigroup | Neutral |
| 2018-01-03 | Iniziato | Evercore ISI | Outperform |
| 2018-01-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
Mostra tutto
Baxter International Inc Borsa (BAX) Ultime notizie
Albireo Energy in Edison appoints Baxter as CEO - ROI-NJ
Baxter International focuses on dialysis and hospital portfolio, shares on NYSE under analyst watch - Ad-hoc-news.de
Baxter International Inc. stock underperforms Monday when compared to competitors - MarketWatch
Baxter Publishes 2025 Sustainability Report Highlighting Refreshed Strategy, Ongoing Commitment to Drive Meaningful Impact - Eagle-Tribune
Baxter International Inc. (BAX) Stock Analysis: Navigating Healthcare Challenges with a Potential 8.3% Upside - DirectorsTalk Interviews
Is Baxter International stock underperforming the S&P 500? - MSN
Baxter's unit Synovis MCA to lead global rollout of the SHIYA platform - MSN
Baxter International Stocklong-term strategy stays in focus after Vantive spin-off - Ad-hoc-news.de
Quietly crucial on the ward, Baxter’s Sigma Spectrum infusion pump in everyday use - AD HOC NEWS
Why Baxter’s Spectrum IQ smart pump is drawing fresh attention in hospitals - AD HOC NEWS
Baxter's Unit Synovis MCA to Lead Global Rollout of the SHIYA Platform - Yahoo Finance
Business News - LatestLY
Quietly precise, Baxter Spectrum IQ aims to make IV pumps less stressful - AD HOC NEWS
Baxter International Inc (BAX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Baxter International Inc (BAX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Smart safety touches, Baxter Spectrum IQ pump aims for quieter hospital days - AD HOC NEWS
symbol__ Stock Quote Price and Forecast - CNN
MediThinQ partners with Baxter unit to distribute 3D platform - Investing.com
Baxter International Unit Signs Distribution Deal for Surgical Visualization Platform - Moomoo
MediThinQ partners with Baxter unit to distribute 3D platform By Investing.com - Investing.com India
Baxter International Inc. stock underperforms Wednesday when compared to competitors - MSN
Baxter International Inc (BAX) Stock Down 5.2% -- Now Undervalued? GF Score: 60/100 - GuruFocus
Baxter International Inc (BAX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Baxter International Inc (BAX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Baxter International Inc (BAX) Institutional Confidence - TradingKey
Baxter International Inc (BAX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Baxter International Inc (BAX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Baxter International Inc (BAX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Is Baxter International Stock Underperforming the S&P 500? - inkl
BAX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Baxter International Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Baxter International Inc. Stock (US0673431090): Valuation and fundamentals in focus - AD HOC NEWS
Reasons to Retain Baxter International Stock in Your Portfolio for Now - Yahoo Finance
Baxter’s Post-Divestiture Profit Focus Might Change The Case For Investing In Baxter International (BAX) - Sahm
Baxter International stock outlook: Is Wall Street bullish or bearish? - MSN
Baxter International Inc. Stock (US0673431090): Analyst reiteration and modest NYSE move keep BAX in - AD HOC NEWS
Baxter International Inc. (BAX) Stock Analysis: Navigating Challenges with a Potential Upside - DirectorsTalk Interviews
Baxter (BAX) Stock After Recent Rebound Is The Discount To DCF Value Warranted - Yahoo Finance
Baxter International Inc. Stock (US0673431090): Analyst reiteration and NYSE move keep healthcare na - AD HOC NEWS
Baxter International Inc. Stock (US0673431090): Analyst reiteration and recent price move in focus - AD HOC NEWS
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Baxter (BAX) Has an Installed-Base-and-Margin-Reset Story Bigger Than a Turnaround Trade - AlphaStreet
Baxter International Inc Stock (US0718131099): Valuation metrics keep S&P 500 healthcare name in foc - AD HOC NEWS
Baxter International Inc. Stock (US0673431090): Earnings trends and valuation in focus - AD HOC NEWS
FMR LLC's Strategic Acquisition of Baxter International Inc. Sha - GuruFocus
Is Baxter International Inc. (BAX) A Good Stock To Buy Now? - Insider Monkey
Citi Downgrades Baxter International to Sell with Lower Price Target - HarianBasis.co
Why Baxter International Inc (BAX) May Struggle to Outperform: A Look at Future Challenges - GuruFocus
Baxter International (BAX) Faces Tough Road Ahead, Says Citi in Downgrade - Yahoo Finance
Baxter International Inc (BAX) Shares Surge 4.1% -- What GF Scor - GuruFocus
Baxter International Inc Azioni (BAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.03%
0.58%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):